Natural compounds show great promise for treating various diseases by precisely adjusting the AMPK/SIRT1/PGC‐1α pathway (Figure 3), providing new approaches for metabolic disorders, brain diseases, and organ damage. Here, PPARGC1A is linked to metabolic disease.